Shades of Grey: Rethinking PD Therapies with a Credibility Spectrum

The authors propose a shift away from the binary "approved vs. alternative" mindset to a spectrum of credibility for therapeutic approaches. This framework evaluates treatments across three key dimensions: 1. Underlying rationale: Is there a plausible mechanism or theory supporting the therapy? 2. Scientific rigor: What kind of evidence exists—clinical trials, observational data, anecdotal? 3. Patient perceptions: How do patients value or perceive the therapy’s impact? This approach doesn’t promote unproven treatments; instead, it supports nuanced, informed discussions grounded in rationale, evidence, and values. Therapy Families Placed on the Spectrum Therapy Family Credibility Level Medications & Devices (e.g., levodopa, DBS) High – Well-established in clinical practice Rehabilitation & Exercise (e.g., PT, LSVT) Moderate–High – Strong evidence for motor benefits Diet & Lifestyle (e.g., Mediterranean, IF, keto) Moderate – Emerging evidence with potential Supplements & Nutraceuticals (e.g., CoQ10, Mucuna) Low–Moderate – Mechanistic rationale; mixed trial data Complementary Therapies (e.g., acupuncture, photobiomodulation) Low – Limited or preliminary research Advanced Experimental Approaches (e.g., gene therapy) Emerging – High rationale; evidence pending Palliative & Supportive Care (e.g., caregiver support) High – Proven to improve quality of life Why It Matters Encourages balanced decision-making—weighing scientific evidence and patient experience Helps determine which therapies need further research, which are ready for clinical discussion, and which require cautious use Promotes clarity and communication between patients, caregivers, and clinicians